Tarsus Pharmaceuticals, Inc. TARS Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Prepaid Expense at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense?
- Tarsus Pharmaceuticals, Inc. (TARS) reported increase (decrease) in prepaid expense of $13.24M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense increased by 251.8% year-over-year, from -$8.73M to $13.24M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s increase (decrease) in prepaid expense has grown at a 33.5% compound annual growth rate (CAGR), from $721K to -$1.72M.